Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.
Saved in:
| Title: | Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study. |
|---|---|
| Authors: | Stephan C; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany., Rieke A; Gemeinschaftsklinikum Mittelrhein, Kemperhof, Koblenz, Germany., Christensen S; Center for Infectious Diseases (CIM), Münster, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Muenster, Münster, Germany., Mauss S; Center for HIV and Hepatogastroenterology, Dusseldorf, Germany., Schreiber S; Gilead Sciences GmbH, Martinsried, Germany., Albuquerque B; Gilead Sciences GmbH, Martinsried, Germany., Heinzkill M; Gilead Sciences GmbH, Martinsried, Germany., Ramroth H; Gilead Sciences Europe Ltd, Uxbridge, UK., Stellbrink HJ; ICH Study Center, Hamburg, Germany. |
| Source: | HIV medicine [HIV Med] 2025 Feb; Vol. 26 (2), pp. 239-251. Date of Electronic Publication: 2024 Oct 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
